Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2024-05-30

FDA Approved: BOSENTAN — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Bosentan from Zydus Pharmaceuticals USA Inc. The update aligns the generic's labeling with the brand's indications f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bosentan (Bosentan)

Snippet

SUPPL AP for BOSENTAN (BOSENTAN)